Eva Ondrouskova

6PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 19, 2026
High-risk genomic features predict extramedullary progression in multiple myeloma with paraskeletal plasmacytomas.

|Aug 26, 2024
Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease.

Martin Stork, Eva Ondrouskova, Michaela Bohunova

|Jun 14, 2024
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs.

Eva Hoferkova, Vaclav Seda, Sona Kadakova

|Mar 14, 2022
Very rare near-haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR-T therapy in 19-year-old male patient.

Tomas Arpas, Hana Jelinkova, Stepan Hrabovsky

|Jan 07, 2022
Transcription factor c-Myb: novel prognostic factor in osteosarcoma.

Kamila Říhová, Monika Dúcka, Iva Staniczková Zambo

|May 04, 2021
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.

Jitka Malcikova, Sarka Pavlova, Barbara Kunt Vonkova

Pageof 1

Frequent Collaborators

3 joint publications

Michael Doubek

2 joint publications

Martin Stork

2 joint publications

Lenka Radova

2 joint publications

Jana Kotaskova